Similar outcomes obtained with four adjuvant cisplatin-based chemotherapy regimens
Similar outcomes obtained with four adjuvant cis
PFS improvement due to local therapy in oligometastatic NSCLC
PFS improvement due to local therapy in oligomet
Locally advanced NSCLC: oral vinorelbine shows better safety profile than etoposide
Locally advanced NSCLC: oral vinorelbine shows b
ULTIMATE: chemotherapy plus bevacizumab beyond first line
ULTIMATE: chemotherapy plus bevacizumab beyond f
New approaches are raising hope for SCLC patients
New approaches are raising hope for SCLC patient
Mutational analysis: on the road to refined standards
Mutational analysis: on the road to refined stan
“The importance of first-line and second-line targeted agents is obvious”
“The importance of first-line and second-line ta
Exploring established and novel EGFR-directed agents
Exploring established and novel EGFR-directed ag
Lung cancer care in Latin America: evolution of modern therapies and challenges to overcome the existing gaps
Lung cancer care in Latin America: evolution of
Expanding treatment options in NSCLC patients with rare mutations: ALK, ROS1, MET, BRAF
Expanding treatment options in NSCLC patients wi
